Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$429.69−0.21 (-0.05%)
Close on Nov 13, 2026Market cap $92.84BP/E 18.3Yield –
Elevance Health statistics
109 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Jan 27, 2027 (estimated, before the open)
- Last ex-dividend date
- Sep 10, 2026
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 17.00
- 1.74
- P/OCF Ratio
- 12.22
- 7.15
Enterprise valuationIndustry
- EV / Sales
- 0.44
- 0.97
- EV / EBIT
- 16.22
- 13.36
- EV / FCF
- 13.51
- 7.00
Share statisticsIndustry
- Shares Change (YoY)
- -3.31%
- -1.32%
- Shares Change (QoQ)
- -0.34%
- -0.09%
- Float
- 216M
- 57M
- Shares Held by Insiders
- 0.18%
- 3.33%
- Shares Held by Institutions
- 94.3%
- 84.6%
Short sellingIndustry
- Short Interest
- 5M
- –
- Short Interest Change
- -11.5%
- -2.56%
- Short % of Float
- 2.11%
- 3.81%
- Short % of Shares Outstanding
- 2.10%
- 3.02%
- Days to Cover
- 3.26
- 4.05
Stock price statisticsIndustry
- 52-Week High
- $450.69
- –
- 52-Week Low
- $274.84
- –
- 20-Day Moving Average
- $427.76
- –
- 50-Day Moving Average
- $415.40
- –
- 200-Day Moving Average
- $375.50
- –
- Average True Range (14)
- $12.45
- –
- Price Change (1 Week)
- 0.96%
- 2.21%
- Price Change (1 Month)
- 0.29%
- 4.21%
- Price Change (3 Months)
- 10.1%
- 2.03%
- Price Change (6 Months)
- 9.42%
- 11.0%
- Price Change (YTD)
- 22.6%
- 8.86%
- Price Change (1 Year)
- 31.2%
- 10.7%
- Price Change (3 Years)
- -6.94%
- 42.9%
- Price Change (5 Years)
- -1.68%
- 42.3%
- Price Change (10 Years)
- 210.0%
- 113.0%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.62
- 0.73
- Relative Strength Index (14)
- 54.9
- 56.3
- Volatility (1 Year)
- 34.6%
- 28.3%
- Beta (5 Years)
- 0.45
- 0.60
MarginsIndustry
- Pretax Margin
- 3.10%
- 13.5%
- EBITDA Margin
- 3.43%
- 13.5%
- FCF Margin
- 3.23%
- 18.5%
Returns on capitalIndustry
- Return on Equity (ROE)
- 11.6%
- 13.9%
- Return on Assets (ROA)
- 4.10%
- 2.97%
- Return on Invested Capital (ROIC)
- 11.0%
- 17.9%
- Return on Capital Employed (ROCE)
- 6.69%
- 5.44%
Financial positionIndustry
- Current Ratio
- 1.47
- 1.47
- Quick Ratio
- 0.76
- 0.97
- Debt / Equity
- 0.69
- 0.32
- Debt / EBITDA
- 4.45
- 2.21
- Debt / FCF
- 4.72
- 2.32
- Net Debt / EBITDA
- -0.71
- -0.97
- Interest Coverage
- 3.76
- 4.66
GrowthIndustry
- Revenue Growth (YoY)
- 3.60%
- 6.46%
- Net Income Growth (YoY)
- -7.12%
- 11.9%
- EPS Growth (YoY)
- -4.13%
- 12.7%
- FCF Growth (YoY)
- 72.9%
- 9.52%
- Revenue Growth (3Y CAGR)
- 8.34%
- 9.53%
- Revenue Growth (5Y CAGR)
- 10.3%
- 8.29%
- EPS Growth (3Y CAGR)
- 1.26%
- 15.9%
- EPS Growth (5Y CAGR)
- 6.99%
- 15.2%
EfficiencyIndustry
- Asset Turnover
- 1.61
- 0.27
- Revenue Per Employee
- $2.08M
- $1.80M
- Profits Per Employee
- $52.92K
- $182.48K
- Employee Count
- 97,100
- 1,341
- WACC
- 6.74%
- 8.10%
Income statement (TTM)Industry
- Pretax Income
- $6.25B
- $617.47M
Balance sheetIndustry
- Net Cash (Debt)
- $4.94B
- $331.32M
- Net Cash Per Share
- $22.86
- $5.43
- Equity (Book Value)
- $44.68B
- $3.44B
- Book Value Per Share
- $206.80
- $37.80
- Tangible Book Value
- $5.46B
- $2.32B
- Working Capital
- $21.86B
- $489.26M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.08B
- -$9.40M
- FCF Per Share
- $30.15
- $8.18
Dividends and yieldsIndustry
- Earnings Yield
- 5.54%
- 8.85%
- FCF Yield
- 7.02%
- 12.2%
- Buyback Yield
- 2.33%
- 3.22%
- Shareholder Yield
- 2.33%
- 4.26%
- Payout Ratio
- 29.2%
- 20.1%
- FCF Payout Ratio
- 23.0%
- 17.9%
Taxes and interestIndustry
- Interest Expense
- $1.45B
- $77.46M
- Income Tax
- $1.15B
- $107.00M
- Effective Tax Rate
- 18.4%
- 20.0%
Scores and fair valueIndustry
- Graham Number
- $330.32
- $76.72
- Graham Upside
- -23.1%
- 11.3%
- Altman Z-Score
- 3.01
- 0.94
- Piotroski F-Score
- 6
- 5
- Lynch Fair Value
- $163.99
- –
- Lynch Upside
- -61.8%
- 74.7%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ELV | S&P 500 | Difference | ELV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +1.0% | -3.0% | +4.1 pts | ||
| 3 months | +8.4% | -2.8% | +11.2 pts | ||
| Year to date | +24.4% | +11.5% | +12.9 pts | ||
| 1 year | +33.5% | +13.5% | +20.0 pts | ||
| 3 years | -2.1% | +77.7% | −79.8 pts | -0.7% | +21.1% |
| 5 years | +5.8% | +72.6% | −66.8 pts | +1.1% | +11.5% |
| 10 years | +268.9% | +308.2% | −39.3 pts | +13.9% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
5M ELV shares were sold short on Oct 30, 2026, down 11.5% from the previous report, or 2.11% of the shares available to trade. At recent volumes it would take 3.3 days to buy them back. Over the last 20 sessions, 44.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,544,947 | -11.5% | 1,393,694 | 3.3 |
| Oct 15, 2026 | 5,137,559 | +5.8% | 1,285,082 | 4.0 |
| Sep 30, 2026 | 4,854,598 | -9.0% | 1,236,911 | 3.9 |
| Sep 15, 2026 | 5,335,623 | -2.7% | 1,267,937 | 4.2 |
| Aug 31, 2026 | 5,485,788 | +1.5% | 836,685 | 6.6 |
| Aug 14, 2026 | 5,405,640 | -3.2% | 952,831 | 5.7 |
| Jul 31, 2026 | 5,586,082 | -7.3% | 1,422,031 | 3.9 |
| Jul 15, 2026 | 6,025,314 | +0.3% | 1,709,546 | 3.5 |
| Jun 30, 2026 | 6,009,556 | -4.3% | 1,835,606 | 3.3 |
| Jun 15, 2026 | 6,281,369 | -4.9% | 1,785,160 | 3.5 |
| May 29, 2026 | 6,604,471 | +8.3% | 1,520,194 | 4.3 |
| May 15, 2026 | 6,101,072 | +18.3% | 1,658,684 | 3.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?